Drugeliukas, MB - financials and debts

Company age: 2 y. 0 mo.

Update

Drugeliukas - Company finances

EUR
2024
From: 2024-09-24
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue - 6,061
Profit before tax 0 7,186
Net profit 0 7,186
Equity 0 6,061
Liabilities 0 0
Non-current assets 0 0
Current assets 0 6,061
Total assets 0 6,061
Financial indicators
Revenue change y/y - -
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. - 118.6%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. - 118.6%
Profit margin Net profit margin. Shows the overall profitability of the company. - 118.6%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. - 118.6%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. - -
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. - -

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Drugeliukas - Social security debts

The company had no debts to Sodra

Drugeliukas - VMI tax arrears

As of 2026-09-02, the amount of overdue STI tax debt of the company Drugeliukas is: 367 €

From To Overdue, €
2026-09-01 2026-09-02 367.3
2026-08-02 2026-08-31 364.2
2026-07-05 2026-08-01 361.4
2026-06-18 2026-07-04 364.0

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.